Latest News
Beam Therapeutics Inc.
- Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
- Form 144 BEAM THERAPEUTICS INC. For: 16 October By Investing.com
- Beam suggests it can correct mutation; Pfizer to collaborate with Enodia
- Beam Therapeutics faces securities fraud invest...
- Beam Therapeutics appoints Eric Foster as Chief Commercial Officer
- Beam Therapeutics sues base editing rival, claims former scientist stole secrets
- Beam sues former scientist, two biotechs for alleged theft of AATD gene-editing therapy
- Beam Therapeutics sues over alleged IP theft — STAT News
- Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
- Beam sues 2 biotechs, alleging theft of base editing trade secrets
- Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress (NASDAQ:BEAM)
- Beam Therapeutics faces securities fraud probe after stock drops 9.54% on clinical trial safety concerns
Headlines from the last 30 days, linking to the original publishers. See all market news →